517 related articles for article (PubMed ID: 20530699)
21. Discovery of Hedgehog Antagonists for Cancer Therapy.
Khatra H; Bose C; Sinha S
Curr Med Chem; 2017; 24(19):2033-2058. PubMed ID: 28302010
[TBL] [Abstract][Full Text] [Related]
22. Implications of hedgehog signaling antagonists for cancer therapy.
Xie J
Acta Biochim Biophys Sin (Shanghai); 2008 Jul; 40(7):670-80. PubMed ID: 18604459
[TBL] [Abstract][Full Text] [Related]
23. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913
[TBL] [Abstract][Full Text] [Related]
24. Blockade of hedgehog signaling pathway as a therapeutic strategy for pancreatic cancer.
Xu FG; Ma QY; Wang Z
Cancer Lett; 2009 Oct; 283(2):119-24. PubMed ID: 19232458
[TBL] [Abstract][Full Text] [Related]
25. Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition.
Miyazaki Y; Matsubara S; Ding Q; Tsukasa K; Yoshimitsu M; Kosai K; Takao S
Mol Cancer; 2016 Jun; 15(1):49. PubMed ID: 27349387
[TBL] [Abstract][Full Text] [Related]
26. Hedgehog Signaling: From Basic Biology to Cancer Therapy.
Wu F; Zhang Y; Sun B; McMahon AP; Wang Y
Cell Chem Biol; 2017 Mar; 24(3):252-280. PubMed ID: 28286127
[TBL] [Abstract][Full Text] [Related]
27. Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities?
Rovida E; Stecca B
Semin Cancer Biol; 2015 Dec; 35():154-67. PubMed ID: 26292171
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinic.
Laranjeira AB; Yang SX
Expert Opin Drug Discov; 2016 Nov; 11(11):1071-1080. PubMed ID: 27626707
[TBL] [Abstract][Full Text] [Related]
29. Hedgehog signaling pathway as a new therapeutic target in pancreatic cancer.
Onishi H; Katano M
World J Gastroenterol; 2014 Mar; 20(9):2335-42. PubMed ID: 24605030
[TBL] [Abstract][Full Text] [Related]
30. Hedgehog-GLI signaling drives self-renewal and tumorigenicity of human melanoma-initiating cells.
Santini R; Vinci MC; Pandolfi S; Penachioni JY; Montagnani V; Olivito B; Gattai R; Pimpinelli N; Gerlini G; Borgognoni L; Stecca B
Stem Cells; 2012 Sep; 30(9):1808-18. PubMed ID: 22730244
[TBL] [Abstract][Full Text] [Related]
31. The Hedgehog pathway as a drug target in cancer therapy.
Lauth M; Toftgård R
Curr Opin Investig Drugs; 2007 Jun; 8(6):457-61. PubMed ID: 17621875
[TBL] [Abstract][Full Text] [Related]
32. Salinomycin induces selective cytotoxicity to MCF-7 mammosphere cells through targeting the Hedgehog signaling pathway.
Fu YZ; Yan YY; He M; Xiao QH; Yao WF; Zhao L; Wu HZ; Yu ZJ; Zhou MY; Lv MT; Zhang SS; Chen JJ; Wei MJ
Oncol Rep; 2016 Feb; 35(2):912-22. PubMed ID: 26718029
[TBL] [Abstract][Full Text] [Related]
33. Translating Hedgehog in Cancer: Controlling Protein Synthesis.
D'Amico D; Canettieri G
Trends Mol Med; 2016 Oct; 22(10):851-862. PubMed ID: 27591077
[TBL] [Abstract][Full Text] [Related]
34. Modulators of the hedgehog signaling pathway.
Heretsch P; Tzagkaroulaki L; Giannis A
Bioorg Med Chem; 2010 Sep; 18(18):6613-24. PubMed ID: 20708941
[TBL] [Abstract][Full Text] [Related]
35. Hedgehog pathway and smoothened inhibitors in cancer therapies.
Chahal KK; Parle M; Abagyan R
Anticancer Drugs; 2018 Jun; 29(5):387-401. PubMed ID: 29537987
[TBL] [Abstract][Full Text] [Related]
36. Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies.
Mimeault M; Batra SK
Pharmacol Rev; 2010 Sep; 62(3):497-524. PubMed ID: 20716670
[TBL] [Abstract][Full Text] [Related]
37. Inhibiting Hedgehog: An Update on Pharmacological Compounds and Targeting Strategies.
Galperin I; Dempwolff L; Diederich WE; Lauth M
J Med Chem; 2019 Sep; 62(18):8392-8411. PubMed ID: 30986059
[TBL] [Abstract][Full Text] [Related]
38. Clinical experience with Hedgehog pathway inhibitors.
Low JA; de Sauvage FJ
J Clin Oncol; 2010 Dec; 28(36):5321-6. PubMed ID: 21041712
[TBL] [Abstract][Full Text] [Related]
39. Advances in targeting the Hedgehog signaling pathway in cancer therapy.
Kiesslich T; Neureiter D
Expert Opin Ther Targets; 2012 Feb; 16(2):151-6. PubMed ID: 22233124
[TBL] [Abstract][Full Text] [Related]
40. Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion.
Varnat F; Duquet A; Malerba M; Zbinden M; Mas C; Gervaz P; Ruiz i Altaba A
EMBO Mol Med; 2009 Sep; 1(6-7):338-51. PubMed ID: 20049737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]